advertisement

Topcon

Liao J 17

Showing records 1 to 17 | Display all abstracts from Liao J

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Lin J; Deng W
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Liao J
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Ke D
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lin J; Huang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Cui L
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Zhong H; Huang K
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q; Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Jiang L; Chen Q
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Xu F
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jiang L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Tang F
International immunopharmacology 2024; 126: 111287
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cui L; Zhong H; Li M; Wei Y; Xu F
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

Issue 24-4

Change Issue


advertisement

Nidek